Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.76

-2.1%

Dec 30 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Findit who wrote (142)	12/6/2002 12:26:54 PM
From: Jibacoa	Read Replies (2) of 3722

DNDN Is up 25.46% on volume of 354K (about 7x its daily average) after it announced today that, following discussions with the FDA, it will amend its current Phase III trial of Provenge to enroll only advanced hormone resistant prostate cancer patients with a Gleason score of 7 or less. bigcharts.marketwatch.com The stock is now trading above its August 16 H but still below its April 5 H.(That was after it closed its January10-January 11 down-gap from 8.05 to 4.57)<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next